Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Solid Biosciences Inc SLDB

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3... see more

Recent & Breaking News (NDAQ:SLDB)

Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer

GlobeNewswire October 2, 2023

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire September 20, 2023

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire September 5, 2023

Solid Biosciences to Participate in Citi's 18th Annual BioPharma Conference

GlobeNewswire August 31, 2023

Solid Biosciences Provides Second Quarter Business Update and Financial Results

GlobeNewswire August 14, 2023

Solid Biosciences to Participate at the Jefferies Healthcare Conference

GlobeNewswire June 1, 2023

Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit

GlobeNewswire May 22, 2023

Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting

GlobeNewswire May 16, 2023

Solid Biosciences Provides First Quarter Business Update and Financial Results

GlobeNewswire May 11, 2023

Solid Biosciences to Present at JMP Securities Life Sciences Conference

GlobeNewswire May 8, 2023

Solid Biosciences to Participate in Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

GlobeNewswire April 21, 2023

Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference

GlobeNewswire April 13, 2023

Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results

GlobeNewswire March 23, 2023

Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery

GlobeNewswire March 21, 2023

Solid Biosciences to Present at Barclays Global Healthcare Conference

GlobeNewswire March 7, 2023

Solid Biosciences to Present at SVB Securities Global Biopharma Conference

GlobeNewswire February 8, 2023

Pathway Development Consortium Announces Publication in Human Gene Therapy on the Application of FDA's Accelerated Approval Pathway for AAV Gene Therapies for Patients with Duchenne Muscular Dystrophy

GlobeNewswire January 26, 2023

Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases

GlobeNewswire January 11, 2023

Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases

GlobeNewswire January 10, 2023

Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer

GlobeNewswire January 9, 2023